| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027472 |
| Receipt No. | R000031471 |
| Scientific Title | Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) |
| Date of disclosure of the study information | 2017/05/24 |
| Last modified on | 2020/11/25 (Ver. 3) |
| Basic information | ||
| Public title | Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) | |
| Acronym | Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) | |
| Scientific Title | Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) | |
| Scientific Title:Acronym | Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) | |
| Region |
|
|
| Condition | ||||
| Condition | Healthy volunteers | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Four-Dimensional Phase-Contrast Vastly Undersampled Isotropic Projection Reconstruction (PC-VIPR) enables the assessment of hemodynamics of the blood vessels.
The purpose of this study is to evaluate the efficacy of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100), and compare with conventional analysis with abdominal ultrasonography (US). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Ratio of SMA flow volume at t=25 min to t=-25 min measured by US and PC-VIPR. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | State of taking daikenchuto(TU-100) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Healthy adults over 20 years old
2.Systolic blood pressure under 140mmHg 3.Written informed consent |
|||
| Key exclusion criteria | 1. Person with MRI contraindications (claustrophobic, metal in the body, etc.)
2.High blood pressure 3.The past of the heart disease 4.With the history of abdominal surgery 5.Under the medical treatment 6.Disable to keep face up position 7.Pregnant or possibly pregnant 8.Under the nursing |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hamamatsu University School of Medicine | ||||||
| Division name | Surgery 2, Divisions of Gastroenterological & Vascular Surgery | ||||||
| Zip code | |||||||
| Address | 1-20-1 Handayama, Higashi-ku, Hamamatsu, Japan | ||||||
| TEL | 053-435-2279 | ||||||
| kurachi1@hama-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hamamatsu University School of Medicine | ||||||
| Division name | Surgery 2, Divisions of Gastroenterological & Vascular Surgery | ||||||
| Zip code | |||||||
| Address | 1-20-1 Handayama, Higashi-ku, Hamamatsu, Japan | ||||||
| TEL | 053-435-2279 | ||||||
| Homepage URL | |||||||
| mayu-s@hama-med.ac.jp | |||||||
| Sponsor | |
| Institute | Hamamatsu University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031471 |